Arkolith/Insider Trading/CCXI/Form 4

Kanaya Susan M

EVP, CFO and Sec., DirectorChemoCentryx, Inc. (CCXI) · full profile →Form 4 · filed Aug 8, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.3M
Net Open-Market Flow
-$2.3M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 4, 2022Option exercise(M)15K$6.23$91K106K
Aug 4, 2022Option exercise(M)32K$6.62$210K138K
Aug 4, 2022Sell(S)46K$50.17$2.3M91K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 4, 2022Option exercise(M)32K——77K
Aug 4, 2022Option exercise(M)15K——30K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-044894) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML